scholarly article | Q13442814 |
P50 | author | Mark D. Okusa | Q64163926 |
P2093 | author name string | Hong Ye | |
Gilbert R Kinsey | |||
Liping Huang | |||
Peter I Lobo | |||
Katarzyna Jaworska | |||
David A Becker | |||
Konstantine Khutsishvili | |||
P2860 | cites work | Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1) | Q79699846 |
Pharmacologic characterization of novel adenosine A2A receptor agonists in equine neutrophils | Q80976687 | ||
Regulatory T cells from IL-10-deficient mice fail to suppress contact hypersensitivity reactions due to lack of adenosine production | Q83692734 | ||
Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells | Q84143013 | ||
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection | Q24564396 | ||
Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia | Q24817161 | ||
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 | ||
Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney | Q30304269 | ||
Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection | Q30307834 | ||
Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells | Q30311230 | ||
CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice | Q30433004 | ||
Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney | Q30434337 | ||
Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury | Q30435312 | ||
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. | Q30440525 | ||
Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis | Q30441350 | ||
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation | Q30442067 | ||
Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition | Q30443210 | ||
Evidence based selection of housekeeping genes | Q33299463 | ||
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics | Q34144161 | ||
Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. | Q34193534 | ||
Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation | Q34570144 | ||
Acute kidney injury increases risk of ESRD among elderly | Q34657680 | ||
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease | Q34658933 | ||
Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury | Q35923305 | ||
PD-1 and PD-1 ligands: from discovery to clinical application | Q36868261 | ||
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells | Q37318142 | ||
Turnover of adenosine in plasma of human and dog blood | Q39525884 | ||
CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis | Q39598074 | ||
PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. | Q42017650 | ||
Rapid recruitment of inflammatory monocytes is independent of neutrophil migration | Q44353696 | ||
Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo | Q44528083 | ||
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response | Q45292627 | ||
Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. | Q45922599 | ||
Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10. | Q46120149 | ||
Incidence and outcomes in acute kidney injury: a comprehensive population-based study. | Q51765594 | ||
P433 | issue | 9 | |
P304 | page(s) | 1528-1537 | |
P577 | publication date | 2012-07-26 | |
P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
P1476 | title | Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection | |
P478 | volume | 23 |
Q26749571 | A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment |
Q41625506 | Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism |
Q30300186 | Adenosine 2A receptors in acute kidney injury |
Q52950232 | Adenosine A2 a receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress. |
Q38936385 | Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression. |
Q34735024 | Adenosine receptors and renal ischaemia reperfusion injury |
Q89121829 | Ag-specific CD4 T cells promote innate immune responses in liver ischemia reperfusion injury |
Q27006863 | Attenuating myocardial ischemia by targeting A2B adenosine receptors |
Q28298659 | Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice |
Q30301290 | Both PD-1 ligands protect the kidney from ischemia reperfusion injury |
Q36906658 | CD39 and CD73 in immunity and inflammation |
Q47655859 | CD39-adenosinergic axis in renal pathophysiology and therapeutics |
Q99706828 | CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice |
Q35504129 | CD73 is dispensable for the regulation of inflationary CD8+ T-cells after murine cytomegalovirus infection and adenovirus immunisation |
Q49790592 | Carbon monoxide protects the kidney through the central circadian clock and CD39. |
Q41718154 | Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over |
Q55618915 | Comparison of the expression of cluster of differentiation (CD)39 and CD73 between propofol- and sevoflurane-based anaesthesia during open heart surgery. |
Q97533995 | Conversion of extracellular ATP into adenosine: a master switch in renal health and disease |
Q28072162 | Cyclic AMP Represents a Crucial Component of Treg Cell-Mediated Immune Regulation |
Q38187566 | Delayed kidney graft function: from mechanism to translation |
Q64274419 | Dysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity |
Q50765097 | Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation |
Q36624633 | Endogenous Toll-Like Receptor 9 Regulates AKI by Promoting Regulatory T Cell Recruitment |
Q30414931 | Expanding role of T cells in acute kidney injury |
Q33878542 | Extracellular adenosine-mediated modulation of regulatory T cells |
Q87018915 | Heat-shock protein-70 and regulatory T cell-mediated protection from ischemic injury |
Q36513609 | Human endometrial regenerative cells attenuate renal ischemia reperfusion injury in mice |
Q42484364 | Hypercholesterolemia and Ecto-enzymes of Purinergic System: Effects of Paullinia cupana. |
Q38497062 | IL-10-independent regulatory B-cell subsets and mechanisms of action |
Q38261586 | Immune cells in experimental acute kidney injury |
Q38220701 | Induced regulatory T cells in inhibitory microenvironments created by cancer |
Q38221992 | Ischemia/reperfusion during normothermic perfusion |
Q38341214 | Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. |
Q28080772 | Molecular mechanisms of ischemic preconditioning in the kidney |
Q46026307 | Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives. |
Q30275941 | Proximal Tubule CD73 Is Critical in Renal Ischemia-Reperfusion Injury Protection |
Q38753350 | Purinergic regulation of the immune system |
Q53543423 | Recovery from experimental autoimmune uveitis promotes induction of antiuveitic inducible Tregs. |
Q36752430 | Regulation of Vascular and Renal Function by Metabolite Receptors |
Q26800184 | Regulatory T Cells in Kidney Transplantation: New Directions? |
Q30409790 | Regulatory T cells in AKI. |
Q45066685 | Regulatory T cells in Acute and Chronic Kidney Diseases |
Q98298303 | Regulatory T cells in ischemic cardiovascular injury and repair |
Q50319201 | Regulatory T cells in renal disease. |
Q26798141 | Research Progress on Regulatory T Cells in Acute Kidney Injury |
Q30278837 | Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury |
Q33940412 | T cells in organ ischemia reperfusion injury |
Q60921609 | Targeting Adenosine Receptor Signaling in Cancer Immunotherapy |
Q38063159 | The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury |
Q21131166 | The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation |
Q99712217 | The Yin and Yang of Alarmins in Regulation of Acute Kidney Injury |
Q96230894 | The adenosine pathway in immuno-oncology |
Q39161005 | The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets |
Q40946206 | The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice |
Q99209324 | Treg expansion with trichostatin A ameliorates kidney ischemia/reperfusion injury in mice by suppressing the expression of costimulatory molecules |
Q30411026 | Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway |
Q37733614 | Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window |
Search more.